NCT05554380 2026-03-18Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Suspended33 enrolled